Press Release Archive
Recent Posts
- Cardiac Dimensions Included in the New 2021 ESC Guidelines for Heart Failure Management
September 22, 2021 - Cardiac Dimensions® Announces Launch of Its Optimized U.S. Pivotal Trial – The EMPOWER Trial
August 20, 2021 - Cardiac Dimensions Announces Two New Meta-Analysis Publications Showing Statistically Significant and Clinically Meaningful Benefits to Heart Failure Patients Suffering from Functional Mitral Regurgitation
April 7, 2021 - Cardiac Dimensions Welcomes Robert White to its Board of Directors
April 6, 2021
Recent Posts
- Cardiac Dimensions Announces $17.5 Million Series C Financing to Accelerate Sales Expansion of the Carillon Mitral Contour System
September 29, 2020
Cardiac Dimensions Announces $17.5 Million Series C - Cardiac Dimensions Announces Australian Therapeutic Goods Administration’s Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation
September 2, 2020
Cardiac Dimensions Announces Australian Therapeutic - New Data Confirms Cardiac Dimensions’ Carillon System Shows Favorable Long-Term Survival Rate in Patients with Functional Mitral Regurgitation
February 25, 2020
New Data Confirms Cardiac Dimensions’ Carillon
Recent Posts
- REDUCE FMR Study Shows Cardiac Dimensions’ Carillon System Significantly Improves Mitral Regurgitation and Slows Worsening of Heart Failure
September 12, 2019
REDUCE FMR Study Shows Cardiac Dimensions’ Carillon - Cardiac Dimensions Reaches 1,000 Implants of Carillon System, a Minimally Invasive Treatment for Functional Mitral Regurgitation
July 1, 2019
Cardiac Dimensions Reaches 1,000 Implants of Carillon - New Data Shows The Carillon Mitral Contour System® Is Associated With Improvement In Regurgitant Volume In Patients With Increased Mitral Valve Tenting
June 13, 2019
New Data Shows The Carillon Mitral Contour System® Is - New Data Confirms Cardiac Dimensions’ Carillon System Provides Acute Hemodynamic Efficacy in Patients With Functional Mitral Regurgitation
April 26, 2019
New Data Confirms Cardiac Dimensions’ Carillon - Cardiac Dimensions Appoints Carmelo Mastrandrea as Vice President of Sales
January 15, 2019
Cardiac Dimensions Appoints Carmelo Mastrandrea as
Recent Posts
- Cardiac Dimensions Announces DRG Reimbursement Code for Carillon Mitral Contour System® in Germany
October 18, 2018
Cardiac Dimensions Announces DRG Reimbursement Code - Cardiac Dimensions Announces Positive Late-Breaking Results for Blinded Clinical Trial of Minimally Invasive Heart Failure Treatment
September 23, 2018
Cardiac Dimensions Announces Positive Late-Breaking - Cardiac Dimensions Announces Late-Breaking Data to be Presented at The Transcatheter Cardiovascular Therapeutics Conference (TCT) 2018
September 20, 2018
Cardiac Dimensions Announces Late-Breaking Data to be
Join our mailing list for invitations to studies along with company announcements.
© 2023 Cardiac Dimensions. All rights reserved.
NOTE: The Carillon Mitral Contour System has received CE Mark (0344) and is available for sale in Europe and other countries that recognize CE Mark.
CAUTION: Investigational Device. Limited by United States law to investigational use.
© 2022 Cardiac Dimensions. All rights reserved.